Arthur M. Cohen & Associates LLC Decreases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Arthur M. Cohen & Associates LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,041 shares of the healthcare conglomerate’s stock after selling 639 shares during the period. Arthur M. Cohen & Associates LLC’s holdings in UnitedHealth Group were worth $1,069,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in the business. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the fourth quarter valued at $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on UNH. HSBC restated a “reduce” rating and set a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Barclays reduced their price objective on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research note on Monday. Finally, TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $428.43.

Insider Transactions at UnitedHealth Group

In related news, Director John H. Noseworthy purchased 300 shares of the business’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the acquisition, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. The trade was a 5.21% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John F. Rex acquired 17,175 shares of the company’s stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock valued at $31,607,768 in the last 90 days. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Down 0.3%

Shares of NYSE UNH opened at $300.37 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a 50-day moving average price of $418.00 and a 200 day moving average price of $488.12. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The stock has a market capitalization of $272.48 billion, a price-to-earnings ratio of 19.38, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the firm earned $6.91 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.